Back
46· Steady
Technology6h 2m ago
A preliminary case series suggested a potential association between late immunotherapy infusion timing and reduced pathological complete response (pCR) rates in early-stage Triple-Negative Breast Cancer (TNBC).
Archive Window: 7 Days Left
our institution
Who
patients with early-stage TNBC
What
A preliminary case series suggested a potential association between late immunotherapy infusion timing and reduced pathological complete response (pCR) rates in early-stage Triple-Negative Breast Cancer (TNBC).
When
Fri, 12 Jun 2026 22:36:17 GMT · 6h 2m ago
Where
our institution ·
Why
Emerging evidence suggests that the efficacy of immunotherapy may be influenced by the timing of drug administration, driven by circadian-regulated immune activity.
The Frontline Impact
How this affects you
The findings suggest that the timing of immunotherapy infusions could be a factor in treatment effectiveness for early-stage TNBC, potentially influencing recurrence rates and prompting further research into optimal scheduling for cancer therapies.
Story chain
2 events in this thread- Currently Reading6h 2m agoA preliminary case series suggested a potential association between late immunotherapy infusion timing and reduced pathological complete response (pCR) rates in early-stage Triple-Negative Breast Cancer (TNBC).
- Technology6h 2m agoEarly-day pembrolizumab may boost pCR and cut recurrences, prompting new scheduling questions.Open article